Cedar Brook Financial Partners, LLC Athersys, Inc Transaction History

Cedar Brook Financial Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.18 - $0.86 $3,600 - $17,200	20,000 Added 9.69%	226,435 $59,000
Q4 2021 Jan 27, 2022	BUY	$0.85 - $1.4 $21,250 - $35,000	25,000 Added 13.78%	206,435 $186,000
Q3 2021 Nov 01, 2021	SELL	$1.33 - $1.77 $19,950 - $26,550	-15,000 Reduced 7.64%	181,435 $241,000
Q1 2021 May 11, 2021	SELL	$1.61 - $2.77 $4,830 - $8,310	-3,000 Reduced 1.5%	196,435 $354,000
Q2 2020 Aug 05, 2020	BUY	$1.97 - $3.98 $28,565 - $57,710	14,500 Added 7.84%	199,435 $550,000
Q1 2020 May 07, 2020	BUY	$1.17 - $3.0 $18,326 - $46,992	15,664 Added 9.25%	184,935 $555,000
Q2 2019 Aug 06, 2019	BUY	$1.39 - $2.03 $4,170 - $6,089	3,000 Added 1.8%	169,271 $284,000
Q1 2019 May 08, 2019	BUY	$1.39 - $1.71 $11,120 - $13,680	8,000 Added 5.05%	166,271 $249,000
Q4 2018 Feb 11, 2019	BUY	$1.41 - $2.16 $223,162 - $341,865	158,271 New	158,271 $227,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.